Skip to main content
. 2005 Feb 17;564(Pt 2):563–573. doi: 10.1113/jphysiol.2005.082669

Table 1.

Subject characteristics

Type 2 diabetes, n = 10 Healthy control, n = 7
Age (year) 61 ± 2; 62 ± 2
Weight (kg) 85 ± 5 78 ± 3
BMI (kg m−2) 28.3 ± 1.2* 24.5 ± 0.8
f-B-glucose (mm) 7.9 ± 0.9* 4.7 ± 0.3
f-S-Insulin (pm) 72 ± 17* 39 ± 5
W-B glucose clearance (ml min−1 kg−1)
 28 mU min−1 m−2 2.5 ± 0.6* 5.7 ± 0.9
 480 mU min−1 m−2 8.9 ± 0.7* 14.4 ± 0.7

BMI, Body mass index; f-B, fasting blood; f-S, fasting serum; W-B glucose clearance, whole body glucose clearance (i.e. glucose infusion rate (mg min−1 kg−1) during the final 30 min of 2-h sequential insulin infusions divided by the prevailing plasma glucose concentration (mg (100 ml)−1)).

*

Significantly different from control subjects (P < 0.05). Data are mean ± s.e.m.